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Abstract 
PURPOSE: The purpose of the Doctor of Nursing Practice (DNP) project was to pilot Creating 
Opportunities for Personal Empowerment (COPE), an evidence based cognitive behavioral 
therapy (CBT) intervention, with patients diagnosed with advanced heart failure who are 
awaiting Left Ventricular Assist Device (LVAD) implantation or those who have had one recently 
implanted before they are discharged home.  
METHODS: A cross-sectional study design was used for this Pilot project. Patients were 
identified for potential participation by LVAD coordinators and represent a convenience 
sample. The patients were screened for anxiety and depression using the GAD-7 and PHQ-9 
screening tools. If patients scored a 5 or greater on either tool, they received the COPE CBT 
intervention. COPE is a 7 session CBT intervention with each session lasting 20-30 minutes, 
delivered every three to four days during the patient’s hospitalization following LVAD 
implantation when patient was able to participate. After the sessions were completed, patients 
were re-evaluated for depression and anxiety symptoms with GAD-7 and PHQ-9 tools. 
RESULTS: Five patients were able to participate during the timeframe of this Pilot Project. The 
average scores for depression and anxiety symptoms pre-intervention were 10.6 and 10.2, 
respectively. Post intervention, the scores decreased to an average of 5.4 and 3.2, respectively. 
Due to the small sample size the results did not reach statistical significance. Qualitative data 
reported from the participants suggests that they felt the intervention was helpful.  
CONCLUSION: Though the results did not achieve statistical significance, the decreases in 
average score represent clinically-significant decreases in depression and anxiety symptoms. 
More research is needed to confirm statistical and clinical significance of these findings. This 
project does show that it is possible to implement a multi-session CBT intervention with 
advanced heart failure patients who have recently received LVAD implantation. 
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Background and Significance 
Problem Statement 
The National Institutes of Mental Health (NIMH), reported in 2017 that Major 
Depression affects roughly 7.1% of adults and is the leading cause of disability in the United 
States.  Approximately, 31.1% of adults in the United States have been diagnosed with an 
anxiety disorder (NIMH, 2017). Patients with advanced heart failure are at an increased risk for 
developing symptoms of depression and anxiety (Celano et al., 2018).      
Context, Scope, and Consequences of Problem 
In 2014, there were over 1 million emergency room admissions and just under 1 million 
hospitalizations related to heart failure with each admission costing around $11,000 (Jackson et 
al, 2018). The incidence of depression in patients with heart failure is approximately 20%, which 
is 2-3 times greater than the general population (Rustad et al., 2013; Celano et al., 2018). 
Depression is also associated with increased hospitalizations, arrhythmias, increased 
inflammation and increased mortality. According to Ghosh et al. (2016), the high 30-day 
readmission rates (~17%) for patients with heart failure is partially related to the effects of 
depression and anxiety. Anxiety is also a problem for patients with heart failure with nearly 13% 
meeting diagnostic criteria for generalized anxiety disorder and 30% having clinically significant 
symptoms (Celano et al., 2018).  
Current Evidence Based Strategies  
 A recent meta-analysis by Das et al. (2019) considered 21 randomized control trials 
(RCT) comprising over 4,500 patients. The findings from their analysis suggest that exercise 
therapy followed by cognitive behavioral therapy (CBT) are more effective than anti-depressant 
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therapy, though the results are not strongly conclusive (Das et al, 2019). Multiple studies 
suggest that CBT is effective for addressing the problem of depression and anxiety in patients 
with heart failure (Celano et al., 2018; Dekker et al., 2011; Dekker et al., 2012; Gary et al, 2010; 
Jeyananatham et al., 2017; Lungren et al, 2016). 
 The primary population that Creating Opportunities for Personal Empowerment (COPE), 
a CBT intervention, has been studied with is school-aged children and high school students. 
Several studies that implemented COPE did show positive results with reducing depression and 
anxiety symptoms (Melnyk, Jacobson, Kelly, Belyea et al, 2015; Melnyk, Kelly, & Lusk, 2014; 
Melnyk, Kelly, Jacobson, Arcoleo, 2013; Lusk & Melnyk, 2011). Dr. (Melnyk, et al., 2013 has also 
developed a version of COPE program for adult patients, which was used in this DNP pilot 
study.  
There are significant gaps in the literature concerning the use of CBT in patients with 
heart failure. While there are multiple studies that suggest that it is of some benefit for 
reducing anxiety and depression symptoms, especially in the short term (Freeland et al, 2015; 
Lundgren, Dahlström et al, 2016; Lundgren, Andersson & Johansson, 2015; Rustad et al, 2013; 
Tully et al, 2015), there are questions about factors that contribute to the success or failure of 
CBT for these patients such as the severity of heart failure, activity level, and sleep schedule 
(Smagula et al, 2019). Das, Roy, Schwarzer et al, 2019; Hundt et al., 2018; Jevenatham, 2017; 
Lundgren, Andersson, & Johansson, 2015 suggest that further study is needed to assess the 
factors which could  improve the longitudinal gains from CBT.  A combination of CBT, exercise 
therapy, and pharmacologic agents are helpful useful for treating depression and anxiety in 
patients with heart failure (Das et al, 2019; Gary et al, 2010; Rustad et al, 2013). 
6 
People with cardiovascular disease have an increased incidence of co-morbid psychiatric 
conditions, specifically depression and anxiety. Several studies have substantiated that CBT is 
helpful for treating depression and anxiety symptoms (Dekker et al., 2012; Freedland et al., 
2015; Lundgren et al., 2016). One recent DNP project completed at the University of Kentucky 
demonstrated that patients with cardiovascular disease had a high incidence of depression 
following their heart surgery but a short cognitive behavioral therapy (CBT) intervention was 
beneficial for helping to address some of the post-operative depression and anxiety (Coles, 
2018). Coles found that a short CBT intervention was possible to employ and effective for this 
population even while they were convalescing in the hospital. This current DNP project applies 
some of these findings to patients with heart failure.  
Purpose 
The purpose of this DNP Project was to pilot Creating Opportunities for Personal 
Empowerment (COPE), an evidence based cognitive behavioral therapy (CBT) intervention, with 
patients diagnosed with advanced heart failure who are awaiting Left Ventricular Assist Device 
(LVAD) implantation or those who have had one recently implanted before they are discharged 
home.  
Objectives 
The objectives of this DNP project are two-fold. The first objective was to identify 
patients with advanced heart failure who are experiencing depression and anxiety symptoms to 
capture the scope of the problem in this population. The second was to pilot COPE in patients 
who are recovering from LVAD implantation surgery. The third was to evaluate their symptoms 
of depression and anxiety pre and post intervention. At this time, the current practice at this 
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institution is for the clinical social worker to screen the prospective LVAD recipients for anxiety 
and depression, using the PHQ-9 and GAD-7 tools, as part of the initial work up. However, 
beyond documenting these scores very little is done in terms of psychiatric care. The goal of 
piloting the COPE CBT intervention with this population was to determine if CBT is effective in 
reducing anxiety and depressive symptoms as demonstrated through pre-post PHQ-9 and GAD-
7 scores. This intervention addresses a current gap in the overall care of this patient population. 
Theoretical Framework 
There are two related theories that inform the theoretical framework of this DNP 
project: Theory of Reasoned Action (TRA) which is the progenitor of the Theory of Planned 
Behavior (TPB). Both of these theories were developed by Azjen and Fishbein. The Theory of 
Reasoned Action was developed in 1975 to explain behavioral choices (Fishbein and Azjen, 
1975). In the TRA, attitudes and subjective (societal) norms determine intentions to act which 
lead to behaviors (Fishbein and Azjen, 1975). Attitudes are an individual’s perceptions regarding 
the consequences of a choice (Azjen, 2020). Societal norms are the understood values of 
“everyone else” (Azjen, 2020). Societal norms may not necessarily mean the culture at large but 
could be the family, friend circle, or people of importance surrounding an individual (Azjen, 
2020). TPB adds to TRA by incorporating the idea of perceived behavioral control as a third 
factor that influences behavior. Perceived behavioral control is the degree to which an 
individual feels they can change a situation. In TPB, the sum of these three factors influence the 
individual’s intention to act in one way or another (Azjen, 2020).  
The Theory of Reasoned Action and the Theory of Planned Behavior guided this DNP project 
because CBT, which COPE is based on,  suggests that how one thinks determines feelings which 
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lead to behaviors (Anxiety and Depression Association of America, 2021). Therefore, if behavior 
is to be influenced, changing thoughts regarding a behavior is essential if a positive outcome is 
to be achieved. Depression and anxiety symptoms can cause people to feel poorly and, 
consequently, they may be less likely to be compliant with their treatment regimen. COPE is a 
tool to help people develop more perceived behavioral control and a better attitude for dealing 
with these challenging problems so that they can achieve better health outcomes. An 
illustration of TRA and TPB is included in figure 1. 
Review of Literature 
A literature review was performed in order to assess the level of knowledge regarding 
the treatment of anxiety and depression with CBT in adult patients with heart failure.  A search 
of the CINAHL with full text database using the search terms CBT and Heart failure was 
conducted. 18 articles were found in the initial search. The results were further filtered by peer 
reviewed and research articles which left 11 articles. Articles older than 10 years were excluded 
leaving nine. One more was excluded because it focused on sleep disturbance leaving eight 
articles that were included in this review. The types of articles that were found were: one 
secondary analysis, one review, four randomized control trials, one meta-analysis, and one 
quasi-experimental study.  
A PubMed search was also conducted using the same search terms which yielded 46 
articles. These results were further filtered by looking at those published in the last 10 years 
which left 38. Next full free text filter was applied which yielded 20 results. Finally, only those 
articles that were randomized control trials or meta-analysis were included which left seven. Of 
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those seven, three additional articles were excluded because they focused on the use of CBT for 
insomnia in patients with heart failure leaving four to be included from the PubMed search. 
However, all four of these articles were duplicate findings from the CINAHL search. 
A literature search was also conducted on the APA PsycInfo database using the search 
terms CBT and heart failure. 25 articles were initially returned using those terms. Articles 
outside the years of 2010-2020 were excluded which left 22. Peer reviewed article filter was 
applied yielding 20 articles. Those articles that were duplicates from the other searches were 
excluded as well as ones that did not include the target population of patients with heart failure 
leaving five additional articles to be included in this review. The five articles that were added 
from this search were comprised of one quantitative study, one qualitative study, a meta-
analysis, a review, and a randomized control study. A total of 13 articles were used from these 
three database sources for this literature review. 
The literature was also reviewed on the utilization of COPE. A search of the APA Psycinfo 
database was conducted using the search terms COPE, CBT, and Melnyk. Ten articles were 
returned from this search. Five of the articles focused on the use of COPE with pediatric and 
adolescent patients (Kozlowski et al., 2015; Lusk & Melnyk, 2011, 2013; Mazurek Melnyk et al., 
2014; McGovern et al., 2019). In three articles COPE was used with adults (Buffington et al., 
2016; Hart et al., 2019; Melnyk, Amaya et al., 2015) and one article reported about training 
graduate psychiatric advanced practice nursing students (Lusk et al., 2018). The final article 
discussed lessons learned from implementing COPE in one of the pediatric studies (Lusk & 
Melnyk, 2011).  Pubmed and CINAHL searches were also completed using the same search 
terms. No new articles were returned from these searches.  
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Synthesis of the Literature 
The most important finding from this literature review was that CBT is an effective 
treatment modality for treating symptoms of anxiety and depression in patients with advanced 
heart failure. Two of the reports were meta-analysis, concerning the use of CBT in patients with 
heart failure from 2017 and 2019. The most recent meta-analysis by Das et al. (2019) 
considered 21 randomized control trials (RCT) comprising over 4,500 patients. In addition, they 
reported that exercise therapy and CBT had therapeutic benefits in treating depression and 
anxiety in patients with heart failure (Das et al, 2019). Jeyanantham et al (2017) reported that 
CBT improved depression scores on the Beck Depression Inventory, PHQ-9, and the Ham-D 
scales, both initially and at three months follow up.  Five RCTs reported that CBT is effective in 
reducing anxiety and depression symptoms in patients with heart failure (Cockayne et al., 2014; 
Freeland et al., 2015; Hundt et al., 2018; Lungren et al., 2016; Smagula et al., 2019). In addition, 
Hundt et al (2018) reported that patients who had greater limitations on physical function and 
decreased self-efficacy experienced less benefit from CBT. Tully et al. (2015) reported that the 
use of CBT was significantly associated with improvements in GAD-7 and PHQ-9 scores as well 
as better participation with a community-exercise program. 
Three of the articles in this literature review reported ambivalent findings regarding the 
utility of CBT for patients with heart failure. Smagula et al (2019) reported that about half of 
patients with advanced heart failure who received CBT did not improve with their depression 
and anxiety symptoms. Mejia et al (2014) reported a secondary analysis of Cockayne et al 
(2014) considering the cost effectiveness of nurse guided outpatient CBT compared to self-
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guided outpatient CBT. There was no significant difference in cost effectiveness or 
improvement in QALY (Quality Adjusted Life Years). Gary et al (2010) reported that CBT reduced 
depression scores on HAM-D scale however they were not statistically significant.    
It was also found that more studies were needed to further evaluate the use of CBT in 
patients with advanced heart failure. Cockayne et al., 2014; Mejia et al., 2014; Lungren et al., 
2016; Freedland et al., 2015; Gary et al., 2010 reported offering web-based, discussion board 
type, self-directed, or specialist delivered CBT to their patients. Celano et al (2016) reports that 
depression and anxiety are underdiagnosed in patients with heart failure and that further study 
was needed as did several others (Das et al., 2019; Hundt et al., 2018; Jevenatham et al., 2017; 
Lungren et al., 2016; Smagula et al., 2019). 
There were two significant findings from the literature regarding COPE. The first finding 
that was consistent in nearly all the articles was that it was effective at reducing depression and 
anxiety symptoms. In one adult study, Hart et al (2019) found that depression and anxiety 
symptoms, as measured by Beck Depression Inventory and State- Trait Anxiety scale, showed 
statistically significant improvement following the COPE intervention. The five studies in 
pediatric and adolescent patients all found statistically significant improvements in anxiety and 
depression symptoms as measured by Beck Youth Inventory and SCARED assessment tools.  
 One that did not show statistically significant decreases in both anxiety and depression 
symptoms was Melynk et al. (2015). This study was focused on college freshmen and delivered 
the COPE intervention via online modules (Melynk et al., 2015). However, students that did 
have severe anxiety symptoms before COPE did show statistically significant improvements 
post intervention as indicated by GAD-7 scores (Melynk et al., 2015). The other article that did 
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not show statistically significant improvement in anxiety symptoms was Buffington et al (2016). 
This study evaluated the effect of COPE in female student athletes experiencing stress and 
anxiety while trying to maintain body composition, nutritional status, and improve knowledge. 
Following the COPE intervention, students did experience a decrease in GAD-7 scores but it was 
not statistically significant. However, students in the control group actually experienced an 
increase in their GAD-7 scores, indicating benefit for the COPE intervention.   
The other important finding was that COPE is an intervention that can be applied across 
a broad range of population and by several different means. Hart et al., 2019; McGovern et al., 
2019; Kozlowski et al., 2015; Melnyk et al., 2014; Lusk et al., 2011 show that COPE can be 
applied to children, adolescents, and adults. It is also an intervention that can be shared and 
learned by others as seen in Lusk et al (2018). COPE can be used in the outpatient settling (Lusk 
et al., 2011) delivered by self-guided online modules (Melnyk et al., 2015) and even in schools 
as a lunch group therapy session (McGovern et al., 2019). 
Gaps in Practice 
There are a significant number of gaps in the literature concerning the use of CBT in 
patients with heart failure. There are multiple studies that suggest that it is of some benefit for 
reducing anxiety and depression symptoms, especially in the short term (Freeland et al, 2015; 
Lundgren, Dahlström et al, 2016; Lundgren, Andersson & Johansson, 2015; Rustad et al, 2013; 
Tully et al, 2015). There are questions about factors that contribute to the success or failure of 
CBT for these patients such as the severity of heart failure, activity level, and sleep schedule 
(Smagula et al, 2019). Nearly all of the studies found in this search suggest the need for further 
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study especially for factors to improve longitudinal gains from CBT (Das, Roy, Schwarzer et al, 
2019; Hundt et al., 2018; Jevenatham, 2017; Lundgren, Andersson, & Johansson, 2015). 
It is likely that a combination of CBT, exercise therapy, and pharmacologic agents are 
effective treatment modalities for depression and anxiety in patients with heart failure (Das et 
al, 2019; Gary et al, 2010; Rustad et al, 2013). However, it is important to more fully explore 
each of these components individually.  
Patients with advanced heart failure have an increased risk for co-morbid psychiatric 
illness. Accessing mental health providers and therapeutic modalities such as CBT in the non-
psychiatric acute inpatient setting can be challenging for those presenting with an 
exacerbation of advanced heart failure (Bopp, 2017). Since most CBT interventions take place 
over many weeks, few multi-session interventions have been studied with patients who are 
hospitalized related to heart failure. 
Methods 
 This was a quasi-experimental pretest and posttest design with patients who were 
awaiting Left Ventricular Assist Device (LVAD) implantation or had one recently implanted. 
These patients were screened for interest in participating by the LVAD coordinators. If the 
patient expressed interest, the PI approached and explained about the study and obtained 
informed consent. Subjects were not randomized in this project. Patients are screened with 
PHQ-9 and GAD-7 tools during their LVAD workup by a social worker. It may be an extended 
period of time before the patient is admitted to the hospital for surgery, thus obtaining a new 
baseline score was needed. 
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 COPE is a seven-session, workbook guided, cognitive behavioral therapy (CBT) 
intervention. The individual sessions take approximately 20-30 minutes to complete and the 
patient is given a workbook to practice skills learned in the sessions. Sessions can be spaced out 
to every three to four days for people who are in the hospital. They can also be completed in 
the outpatient setting or via telehealth if they are discharged before being able to complete all 
sessions. Offering CBT to hospitalized patients is an innovative idea because traditionally it is 
offered in the outpatient setting over the course of 12-16 weeks.  
Setting 
This DNP project was conducted at the University of Kentucky Chandler Medical Center, 
the main campus of UK Healthcare (UKHC).This facility is an academic medical center with over 
800 beds, certified as a Level 1 trauma center and has achieved Magnet nursing status. Patients 
with advanced heart failure are placed in cohorts on the cardiovascular (CV) service line which 
is comprised of two units, a 32-bed intensive care unit and 32 bed progressive unit, with an 
additional 40 telemetry beds in another section of the hospital. Every Friday, there is an 
outpatient clinic for patients with advanced heart failure who have received an LVAD. UKMC 
performs an average of 20-30 LVAD implantations per year. At any given time, there are two to 
ten patients with LVADs admitted to the hospital. The average length of stay according to the 
coordinators is two to six weeks following implantation of a new device.  
Congruence with organization mission, goals, and strategic plan 
UK Healthcare (UKHC) presents its core values through the DIReCT acronym which 
stands for Diversity, Innovation, Respect, Compassion, and Teamwork. Deploying an 
intervention to address the mental health needs of a population of patients that has a known, 
15 
largely unmet need fits well with this mission statement. Increasing access to mental health 
services in the acute care setting is in the interest and values of the UK Healthcare enterprise. 
This DNP project is congruent with the mission and goals of the UKHC as it evaluates the use of 
a CBT based intervention in the treatment of symptoms of depression and anxiety in 
hospitalized patients with advanced heart failure. Currently, there is minimal screening of these 
patients for depression and anxiety due to limited resources.  
Stakeholders 
The key stakeholders for this DNP project include:  
Patients and their families. The research in this area is clear that this patient population 
have increased rates of depression and anxiety (Celano et al., 2018) 
Dr. Lacey Buckler- Chief Advanced Practice Officer. 
Dr. Buckler is a panel member as well as a supporter of the implementation of 
this DNP project. 
Dr. Andrew Kolodziej- Medical Director Heart Transplantation 
Dr. Kolodziej is one of the primary physician champions of the implementation of 
this DNP project. He has also committed to serve as a panel member for the DNP 
panel. 
Dr. Rajasekhar Malyala- Cardiothoracic Surgeon 
 Dr. Malyala is the primary surgeon who implants LVADs at UKHC. He expressed 
support for this project because of the need to holistically support these patients 
and address their mental health needs. 
LVAD Coordinators 
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The LVAD coordinator team is comprised of four BSN-prepared registered nurses 
who serve as the primary contact point for these patients. Together they support 
approximately 80 patients who have received LVADs. The coordinators are the 
first people on the medical team to address any issues that these patients 
experience. The issues they take care of range from psycho-social issues to 
medication management and obtaining various resources needed by these 
patients. One of the themes that they have shared is that a significant number of 
the issues are psycho-socially because these issues affect all areas of care.  
Julia Akhtarekhavari BSN- Mechanical Circulatory Support (MCS) Director 
Julia is the manager over the MCS program and her support of this project is 
crucial both for helping to identify patients that may benefit from participating in 
this project as well as being a champion for the project. 
Bedside nurses 
Nurses are the hands, ears, and eyes of the healthcare team. Before formalized 
screening occurs, they may recognize patients that are exhibiting signs of 
depression and anxiety. With additional training, bedside nurses could be trained 
to deliver this CBT intervention.  
Facilitators and Barriers 
There are several facilitators for the implementation of this project. One of the most 
important is that this project matches well with the UKHC Enterprise goals of providing 
innovative and wholistic care for each patient. This DNP project includes an innovative 
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application of cognitive behavioral therapy to address the known problem of depression and 
anxiety in this population.  
One potential barrier is related to the stigma associated with mental illness and mental 
healthcare. Patients may not participate because they do not recognize the symptoms of 
depression and anxiety or the value of mental healthcare. Another barrier could be the time 
commitment of the patients to participate in the project.  
The COPE CBT intervention is an innovative approach to addressing the psychiatric 
needs of patients with advanced heart failure. This intervention has great potential to be 
applied to many other patient populations should this project prove to be successful. COPE has 
been shown to decrease the severity of depression and anxiety symptoms in adults (Hart et al, 
2019).  
Sample 
The DNP project sample was a convenience sample at a single academic medical center. 
Since the PI did not have direct access to the potential participants of this project, the LVAD 
coordinators approached the patients who were going to have an LVAD implanted to  
determine their interest in participating in  this DNP project. LVAD coordinators are BSN 
prepared nurses who organize the care for these patients and have established access to them. 
If the patients expressed interest in learning more about the project, LVAD coordinators 
informed the PI who approached the patients and offered the option of participation in the 
study. Once informed consent was obtained, patients were screened for depression and anxiety 
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symptoms using the PHQ-9 and GAD-7 screening tools. If the patients screened positive for at 
least mild symptoms of depression or anxiety, they were offered the COPE intervention.  
Procedure 
IRB Approval 
Approval for this project was first received from the UK Healthcare Nursing Research 
Council in October of 2020.  Before implementation of this DNP project, an expedited 
application was submitted to the Institutional Review Board (IRB) at the University of Kentucky. 
The IRB was approved in December 2020. The project was implemented soon after and was 
completed on March 15, 2021. 
Description of Evidence-Based Intervention 
COPE was delivered over the course of seven 20 to 30-minute sessions utilizing the 
manual for adults. The sessions were organized by topic in the manual: Thinking, feeling, and 
behaving; Self-esteem and positive thinking/self-talk; Stress and coping; Problem solving and 
setting goals; Dealing with your emotions in healthy ways; Coping with stressful 
situations/valuable Sleep; and Pulling it all together for a healthy you.  The sessions were 
conducted every three days while the patients were recovering in the hospital as they were 
ready to participate. Patients were assessed for readiness based on a glascow coma scale of 15 
and stating they were ready to participate. Most of the patients completed the first session 
before their surgery. If the patients were discharged before all the sessions could be 
completed, zoom calls were scheduled at convenient times at the same interval in order to 
complete all the sessions. Following the final session, the participants received follow up 
screening for depression and anxiety using the PHQ-9 and GAD-7 tools. 
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Measures and Instruments 
Demographic data (age, gender, highest level of education, employment status, marital 
status, and New York Heart Failure classification score) was collected from participant chart. In 
order to assess depression and anxiety symptoms in patients with heart failure, it is important 
to use valid and reliable screening tools. The tools that were used in this DNP project were the 
GAD-7 and the PHQ-9. The GAD-7 tool was developed by Spitzer et al (2006) because there was 
a need for a simple assessment for generalized anxiety disorder. It is a seven-question 
assessment where patients rate how frequently various symptoms have bothered them in the 
past two weeks. It has been shown to have reliable sensitivity and specificity for identifying 
generalized anxiety disorder (Spitzer et al., 2006). The rating options are “not at all, several 
days, more than half the days, and nearly every day”, which correspond to scores of 0,1,2,3 
respectively (Spitzer et al., 2006). The scored responses to the seven questions are summed 
which yields an overall score from 0 to 21, score cut offs at 5, 10, and 15 represent mild, 
moderate, and severe symptoms (Spitzer et al., 2006). The GAD-7 tool has good internal 
consistency with a Cronbach’s alpha of between 0.79-0.91 (Dear et al., 2011). 
The PHQ-9 was developed by Kroenke et al (2001) from the PRIME-MD diagnostic tool. 
The PHQ-9 scores nine criteria from the DSM IV for depression. Patients are asked to consider 
the nine questions in the timeframe of the past two weeks. They rate how often they 
experience various symptoms from not at all to nearly every day. The responses are given a 
score of zero to three and summed together for a total of zero to 27. The scoring cutoffs for the 
PHQ-9 tool are 5, 10, 15, and 20 which correlate with mild, moderate, moderately severe, and 
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severe depression (Kroenke et al., 2001).  According to the American Psychological Association, 
the PHQ-9 tool has Cronbach’s alpha between 0.86-0.89 (2011). 
Data Collection 
Data was collected pre intervention included: demographic information, PHQ-9 and 
GAD-7. Post intervention data was collected on the PHQ-9 and GAD-7. All data was entered into 
the REDcap application via the PI’s mobile device for secure data storage. Data was de-
identified and assigned random subject ID.  
Data Analysis 
All data was analyzed using SPSS statistical software version 25 with an alpha of 0.05.  
Frequency distributions were used to summarize the demographic characteristics of the 
participants. Pre-intervention and post intervention scores were evaluated using the paired t-
test.   
Results 
Demographics 
The demographic characteristics are shown in table 1. Six patients were identified 
during the timeframe of this study; five were included based on their screening scores on the 
PHQ-9 and GAD-7 tools. A score of 5 or greater on either tool was needed for inclusion to the 
intervention. One was excluded due to not scoring 5 or higher on either tool.  The gender 
characteristics of the participants were four male and one female. Three of the participants 
were married and two were single. The educational level that the patients had achieved was 
either high school or college degree. Sixty percent had completed high school and forty percent 
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had completed a college degree. All of the participants were Caucasian and unemployed 
between 28 and 71 years of age. The average age of the patients was 57 years old. 
Findings 
The average initial PHQ-9 and GAD-7 scores for the participants were 10.6 and 10.2, 
respectively. The PHQ-9 tool has been shown to have 88% sensitivity and 88% specificity for 
identifying major depressive disorder at scores greater than or equal to 10 (Kroenke et al., 
2001). The GAD-7 tool has been shown to have 89% sensitivity and 82% specificity for 
identifying generalized anxiety disorder at scores 10 or above (Spitzer et al., 2006). These initial 
scores suggest that the participants likely were experiencing moderate depression and anxiety 
before implantation of their LVAD device. 
Following the COPE CBT intervention, the average scores decreased to 5.2 and 3.4 (PHQ-
9 and GAD-7). These scores indicate that the depression and anxiety symptoms decreased to 
mild or minimal at the end of the intervention. Unfortunately, the p-value for the differences in 
these pre-post scores did not reach a level of statistical significance, likely due to the small 
sample size. Frequency distributions were used to summarize the demographic characteristics 
of participants. Pre-intervention and post-intervention scores were evaluated using the paired 
t-test. All analysis was conducted using SPSS, version 25 with an alpha of .05. The results can be 
viewed in table 3. 
There were some important qualitative results from this study. All of the patients 
expressed appreciation for the study intervention and felt that it was valuable and helpful. A 
family member of one of the participants reported that their loved one’s mood improved 
significantly after they began participation with this DNP project. They noted that “since having 
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two counseling meetings, his mood has been less labile, he has been getting out of the house to 
go visit friends, sleeping better, and just shown an overall improvement in his mental health.”  
This participant had initially not scored high enough before implantation of the LVAD to 
receive the intervention while he was in the hospital. However, his LVAD coordinator and a 
family member became concerned about him after he was discharged from the hospital. During 
his first follow-up appointment 2 weeks after discharge, he was re-screened for depression and 
anxiety and found to be experiencing mild symptoms by both PHQ-9 and GAD-7 tools. He 
participated in the intervention via zoom appointments and experienced benefit from the 
therapy sessions. 
Another patient, during the final session of the CBT intervention, cried and hugged the 
PI. “You don’t know how much this has meant to me.” He reported that he had felt scared 
about going home but was grateful to have some new strategies to get through future 
challenges.  
Discussion 
The findings from this DNP project support the implementation of the COPE program for 
adults for reducing both depressive and anxiety symptoms in patients who have received an 
implanted LVAD. The results of this project are similar to those reported by Ishak et al (2020) in 
their meta-analysis of depression in heart failure. They report that depressive symptoms have a 
prevalence in up to 85% of patients with heart failure (Ishak et al., 2020). The prevalence of 
mild to moderate depressive symptoms in this DNP project was 83%.  It is possible that this 
finding is due to concerns regarding their impending surgery and hospitalization. However, this 
result does support recommendations by the American Heart Association that patients with 
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advanced heart failure should be screened for depression (Lichtman et al., 2008; Merschel, 
2020).  
"Depression and depressive symptoms are not just in the brain," Celano said. "Your brain is 
connected to every other part of your body. We know more and more that these connections 
between the brain and the rest of the body go both ways. So things that happen in your body can 
affect how you think and feel. And changes in your brain can affect many different parts of your 
body, including your heart." (Merschel, 2020) 
Most of the patients, who participated in this DNP project, screened positive for mild to 
moderate anxiety. Both anxiety and depression are associated with poor outcomes for patients 
with heart failure (Celano et al., 2018) and this DNP project highlights the need both for further 
study and continued intervention to address these conditions.  
Implications 
Offering short CBT interventions to patients with advanced heart failure and 
cardiovascular disease while they are hospitalized has shown positive results (Coles, 2018; 
Dekker et al., 2012). Most patients with hospital admissions related to heart failure have an 
average length of stay less than 6 days (Tashtish et al., 2017). However, patients who receive 
implantation of LVAD are usually hospitalized for 2-6 weeks at this institution. This timeframe 
provides an excellent opportunity to offer patients CBT while they are recovering from their 
surgery. This DNP project presents some interesting findings regarding the use of CBT with 
patients in the acute hospital setting. The reduction in anxiety and depressive symptoms aligns 
with previous findings that CBT is effective for patients with advanced heart failure.  
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Future studies could also consider enrolling the primary caregiver in addition to the 
patient receiving the LVAD. According to Bidwell et al (2016), caregivers experience a decrease 
in quality of life following LVAD implantation, despite improvement for the patient. Some of the 
decreased quality of life was related to stress, anxiety, and depression. COPE could be 
beneficial for the primary caregiver was well as the patient. 
Further research is needed to see if the benefits are sustained such as reduced 
readmission rates, decreases incidence of gastrointestinal bleeding, decreased incidence of 
drive line infection, and decreased depression and anxiety symptoms. If these benefits persist 
then further investment in this kind of intervention is warranted. It is also important to assess 
for longitudinal benefits such as effects on readmission rates, other quality indicators such as 
driveline infection rates, incidence of gastrointestinal bleeding, and one-year survival rate. An 
embedded psychiatric nurse practitioner could be the ideal way to solidify the implementation 
of CBT at this institution. In addition to offering therapy, a psychiatric nurse practitioner could 
also work in conjunction with the medical team to provide medication management for anxiety 
and depressive symptoms which are common in this population. A systematic review by 
Oldham et al (2019) concluded that there appears to be some benefit to a collaborative care 
model incorporating psychiatric services with the primary medical management of general 
hospital patients. Their review showed a decrease in length of stay and favorable cost-benefit 
for the enhanced care (Oldham et al, 2019).  
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Limitations 
There are several limitations related to this project. One of the most significant was the sample 
size (n=5). Due to the small sample size the effects of the intervention did not reach statistical 
significance though they did show clinical significance with the reduction in average scores on 
the PHQ-9 and GAD-7 tools. A larger sample size performed at multiple centers with follow up 
at 6 and 12 months could help solidify the hypothesis that these results would become 
statistically significant and potentially lead to long-term benefits for the participants. 
The participants were homogenous with regard to ethnicity and gender. All of the 
patients were Caucasian and five were male. A larger sample set with greater diversity of 
participants both in terms of gender and ethnicity would make findings more generalizable 
especially considering heart failure has an increased prevalence in other ethnicities and races 
compared to Caucasians (Virani et al., 2020).  
 Another limitation of this project is the lack of randomization with regard to who 
received the pilot intervention.  Some might suggest that the improvements in the depression 
and anxiety scores are related to the patient’s general recovery and adjustment to the LVAD 
rather than benefits of the CBT. By randomizing patients to receive standard care and CBT, the 
effects of the CBT could be compared to the general improvement and alleviation of heart 
failure symptoms that patients generally experience once the device in implanted. 
Conclusion 
The purpose of this DNP project was to pilot Creating Opportunities for Personal 
Empowerment (COPE), an evidence based cognitive behavioral therapy (CBT) intervention, with 
patients diagnosed with advanced heart failure who are awaiting Left Ventricular Assist Device 
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(LVAD) implantation or those who have had one recently implanted before they are discharged 
home. These patients have an increased risk for anxiety and depression especially considering 
the 5-year survival rate after first hospital admission is only 25% (Jeyanantham et al., 2017). In 
addition to the high risk for mortality, patients with LVADs also have the stress of managing an 
implanted device which requires significant lifestyle modifications and additional stressors 
including worries about pump failure, burdening their families and loved ones, not being able to 
participate in activities that they previously enjoyed (Costelle, 2019). All participants 
demonstrated symptoms of depression and/ or anxiety and the COPE program was successfully 
implemented for all five participants. This project demonstrated that using a multi-session CBT 
based intervention, such as COPE, was effective in decreasing the severity of depression and 
anxiety symptoms in hospitalized patients with an LVAD. Although the results were not 
statistically significant, they indicated that the COPE intervention could be beneficial. 
Participants experienced clinically significant decreases in severity of anxiety and depressive 
symptoms. In addition, the patients consistently stated that they felt better after participation 
in this project. 
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Highest Educational Level 
 High School 




 Caucasian 5 (100) 
Employment Status 
 Unemployed 5 (100) 
New York Heart Association Heart Failure Score 
  Class II 






N Minimum Maximum Mean Std. Deviation 










PHQ-9 10.6 (6.3) 5.2 (3.3) .21 
GAD-7 10.2 (6.6) 3.4 (4.9) .1 
Figure 1 
Image obtained from: https://en.wikipedia.org/wiki/Theory_of_planned_behavior 
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